TY - JOUR
T1 - Risk factors for infertility and barriers to treatment in Tanzania
T2 - a survey and medical records study
AU - Groene, Emily A.
AU - Mutabuzi, Cyrialis
AU - Chinunje, Dickson
AU - Shango, Ester
AU - Mkhoi, Mkhoi L.
AU - Mason, Susan M.
AU - Kulasingam, Shalini
AU - Majinge, Charles R.
N1 - Publisher Copyright:
© 2023 Groene EA et al. Licensee African Health Sciences.
PY - 2023/12/27
Y1 - 2023/12/27
N2 - Background: The burden of infertility is serious for women in high-fertility countries. Objectives: We sought to identify demographic, behavioral/environmental, and reproductive risk factors for various infertility factors (i.e., ovarian, tubal, uterine/cervical, male/other) among women seeking infertility treatment in central Tanzania; to determine the association between pelvic inflammatory disease (PID) and tubal factor infertility (TFI); and to identify barriers to infertility treatment by women’s home regional zone. Methods: We conducted a cross-sectional survey of women seeking infertility treatment in Dodoma, Tanzania from January-March 2020. We surveyed 168 participants aged 18-49 years and reviewed their medical records to confirm infertility status and potential risk factors. We estimated prevalence ratios for factors associated with infertility using logistic regression. Treatment barriers were compared by women’s regional zone to see if barriers varied geographically. Results: The median age of participants was 32 years (range: 18-48). Infertility factors did not vary greatly by patient demographics, behavioral/environmental, or reproductive risk factors. Approximately 31.48% of women had PID diagnoses. Those with PID had 1.94 (95% CI: 1.30, 2.90) times the prevalence of TFI diagnosis as those with other infertility factors, after adjusting for age, pesticide use, alcohol use, age at sexual debut, prior obstetric events, and family history of infertility. Logistical barriers to treatment, such as time and cost, were more frequently reported than emotional, stigma, or other barriers, regardless of regional zone. Conclusions: PID was strongly associated with TFI after adjustment for confounders. Infertility treatment access due to cost remains a challenge in Tanzania.
AB - Background: The burden of infertility is serious for women in high-fertility countries. Objectives: We sought to identify demographic, behavioral/environmental, and reproductive risk factors for various infertility factors (i.e., ovarian, tubal, uterine/cervical, male/other) among women seeking infertility treatment in central Tanzania; to determine the association between pelvic inflammatory disease (PID) and tubal factor infertility (TFI); and to identify barriers to infertility treatment by women’s home regional zone. Methods: We conducted a cross-sectional survey of women seeking infertility treatment in Dodoma, Tanzania from January-March 2020. We surveyed 168 participants aged 18-49 years and reviewed their medical records to confirm infertility status and potential risk factors. We estimated prevalence ratios for factors associated with infertility using logistic regression. Treatment barriers were compared by women’s regional zone to see if barriers varied geographically. Results: The median age of participants was 32 years (range: 18-48). Infertility factors did not vary greatly by patient demographics, behavioral/environmental, or reproductive risk factors. Approximately 31.48% of women had PID diagnoses. Those with PID had 1.94 (95% CI: 1.30, 2.90) times the prevalence of TFI diagnosis as those with other infertility factors, after adjusting for age, pesticide use, alcohol use, age at sexual debut, prior obstetric events, and family history of infertility. Logistical barriers to treatment, such as time and cost, were more frequently reported than emotional, stigma, or other barriers, regardless of regional zone. Conclusions: PID was strongly associated with TFI after adjustment for confounders. Infertility treatment access due to cost remains a challenge in Tanzania.
KW - Infection
KW - Infertility
KW - Tanzania
UR - http://www.scopus.com/inward/record.url?scp=85181942823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85181942823&partnerID=8YFLogxK
U2 - 10.4314/ahs.v23i4.50
DO - 10.4314/ahs.v23i4.50
M3 - Article
C2 - 38974292
AN - SCOPUS:85181942823
SN - 1680-6905
VL - 23
SP - 462
EP - 471
JO - African Health Sciences
JF - African Health Sciences
IS - 4
ER -